Inhalation & nasal product development

At Recipharm we support New Drug Application (NDA), generic and 505(b)(2) regulatory pathways. Our dedicated team for development of inhalation formulations supports various dosage forms for new chemical entities (NCEs) and active pharmaceutical ingredients (APIs).

Learn more about our capabilities by downloading our fact sheet below.
 
/sites/default/files/media/FactSheet_Inhalation-and-nasal-product-development.pdf
False
False